ライフサイエンスコーパス: pulmonary infiltrate

1 n a child with sickle cell disease and a new pulmonary infiltrate.

2 lanoma presented with the chief complaint of pulmonary infiltrates.

3 noninfectious complications that manifest as pulmonary infiltrates.

4 and an increase in macrophage percentage in pulmonary infiltrates.

5 y-function tests or resolution or absence of pulmonary infiltrates.

6 ICU over a 3-year period, 44% (40) developed pulmonary infiltrates.

7 en patients died, developing PR with diffuse pulmonary infiltrates.

8 tors of pneumonia versus other etiologies of pulmonary infiltrates.

9 alter CTL generation or to affect Ad-induced pulmonary infiltrates.

10 score of 5 or 6 with an SUV(max) of 2.45 in pulmonary infiltrates.

11 or supplemental oxygen (all forms), and with pulmonary infiltrates.

12 but, of 6 patients at level III, 1 developed pulmonary infiltrates, 1 developed hypotension (both res

13 patient presenting with fever, hypoxia, and pulmonary infiltrates after OLT for hepatitis C.

14 After comparing the SUV(max) of pulmonary infiltrates among different CO-RADS categories

15 ded when a computed tomography scan showed a pulmonary infiltrate and bronchoalveolar fluid (BALf) sa

16 th 67% and 59% of participants demonstrating pulmonary infiltrates and abnormal perfusion, respective

17 woman presented to the hospital with nodular pulmonary infiltrates and acute renal failure.

18 ing a mortality rate of 50% in subjects with pulmonary infiltrates and an overall mortality of 33.3%.

19 January 2020 to January 2024 for unexplained pulmonary infiltrates and had >=1 PCR targeting Aspergil

20 but reversible early graft dysfunction with pulmonary infiltrates and hypoxemia, attributed to ische

21 50%) developed severe graft dysfunction with pulmonary infiltrates and hypoxemia.

22 r infusion, they became critically ill, with pulmonary infiltrates and lung injury, renal failure, an

23 ce of severe graft dysfunction manifested as pulmonary infiltrates and severe hypoxemia with onset in

24 Repeated episodes can result in nodular pulmonary infiltrates and suspected nonspecific intersti

25 pulmonary tuberculosis, one having fever and pulmonary infiltrates and the other having subclinical d

26 ional history in the patient presenting with pulmonary infiltrates and/or fibrosis.

27 ction in lung with LRTD symptoms without new pulmonary infiltrates), and proven (PIV detection in lun

28 lmonary edema, refractory hypoxemia, diffuse pulmonary infiltrates, and altered lung compliance.

29 characterized by consistent viral shedding, pulmonary infiltrates, and elevated inflammatory cytokin

30 rent episodes of wheezing, mucus production, pulmonary infiltrates, and elevated levels of serum IgE.

31 corticosteroids with resolution of hypoxia, pulmonary infiltrates, and glomerulonephritis.

32 I, and they presented more often with shock, pulmonary infiltrates, and renal dysfunction (p < 0.0001

33 ear and take an unusual course, even when no pulmonary infiltrates appear.

34 bronchospasm, suspected pulmonary infection, pulmonary infiltrates, aspiration pneumonitis, atelectas

35 gns, use of supplemental oxygen, presence of pulmonary infiltrates at admission, and hospital site.

36 In 4 neonates, pulmonary infiltrates at presentation were bilateral and

37 olonization, IgE and IgG anti-Af antibodies, pulmonary infiltrates, bronchiectasis, and pulmonary fib

38 dentifying pneumonia as a potential cause of pulmonary infiltrates, but for the likely etiology of th

39 Six subjects had pulmonary infiltrates, but in 3 cases there were no abno

40 Development of pulmonary infiltrates, cardiomyopathy, and eosinophilia

41 Clinical presentations included asymptomatic pulmonary infiltrates, chronic cough, and shortness of b

42 primed for a strong cytolytic response and a pulmonary infiltrate consisting primarily of mononuclear

43 .v. yeast wall glucan developed consolidated pulmonary infiltrates consisting predominantly of macrop

44 of organism-mediated pulmonary injury and of pulmonary infiltrates detected by thoracic computed tomo

45 mbocytopenia, hypersensitivity reaction, and pulmonary infiltrates (fatal in two patients).

46 eumonia, accurately identified patients with pulmonary infiltrates for whom monotherapy with a short

47 sis in 73 nonimmunocompromised patients with pulmonary infiltrates for whom the test was ordered.

48 se pulmonary infiltrates group than in local pulmonary infiltrates group or in pleural effusion group

49 e time to onset of PR was shorter in diffuse pulmonary infiltrates group than in local pulmonary infi

50 hest syndrome (ACS) is the presence of a new pulmonary infiltrate in combination with fever or respir

51 Chest radiographs showed pulmonary infiltrates in all patients.

52 Diffuse pulmonary infiltrates in early phase of anti-tuberculosi

53 alent, but unnecessary in most patients with pulmonary infiltrates in the ICU.

54 utive liver transplant recipients developing pulmonary infiltrates in the ICU.

55 therapy in liver transplant recipients with pulmonary infiltrates in the intensive care unit (ICU).

56 ious pulmonary complications that present as pulmonary infiltrates include idiopathic pneumonia syndr

57 ficiency virus-specific cytotoxic T cells in pulmonary infiltrates, increased survival time, and a re

58 CE2-floxed mice experienced lethal cachexia, pulmonary infiltrates, intravascular thrombosis and hypo

59 Inappropriate antibiotic use for pulmonary infiltrates is common in the intensive care un

60 had evidence of mediastinitis and extensive pulmonary infiltrates late in their course of illness.

61 esent with hypoxemic respiratory failure and pulmonary infiltrates, meeting criteria for acute respir

62 previous infiltrates (n = 5; 55.6%) and new pulmonary infiltrates (n = 8; 88.9%).

63 -) animals had eosinophilic and neutrophilic pulmonary infiltrates not present in wild-type or IFN-ga

64 lized for CAP; 5.4% had PO-CAP, defined as a pulmonary infiltrate occurring distal to an obstructed b

65 lvement (RD, 25.5%; 95% CI, 13.9% to 37.0%), pulmonary infiltrates (odds ratio, 4.9; 95% CI, 1.5-16.2

66 I, 1.2-55.2]; p = 0.032), and more extensive pulmonary infiltrates (odds ratio, 9.7 [95% CI, 3.6-25.9

67 revealed the presence of eosinophils in the pulmonary infiltrate of the vaccinated children.

68 Pulmonary infiltrates of cytotoxic lymphocytes, the lack

69 s syndrome presents as hypoxia and bilateral pulmonary infiltrates on chest imaging in the absence of

70 of > 0.5 while intubated, bilateral diffuse pulmonary infiltrates on chest radiograph, and exclusion

71 in the 90 days before symptom onset and had pulmonary infiltrates on imaging and whose illnesses wer

72 espiratory disease; they also showed reduced pulmonary infiltrates on radiographs and reduced virus t

73 CI, 1.6 to 3.7), and multilobar radiographic pulmonary infiltrate (OR = 3.1; 95% CI, 1.9 to 5.1).

74 gns: fever (body temperature >38 degrees C), pulmonary infiltrates, or the need for supplemental oxyg

75 ry response system-like features of dyspnea, pulmonary infiltrates, pleural and pericardial effusions

76 unexplained fever, weight gain, dyspnea with pulmonary infiltrates, pleuropericardial effusion, hypot

77 iratory distress syndrome, bronchospasm, new pulmonary infiltrates, pulmonary infection, aspiration p

78 ack male with sickle cell disease, bilateral pulmonary infiltrates, refractory hypoxemia, and unstabl

79 Pulmonary infiltrates seen on chest radiographs correspo

80 Pulmonary infiltrating T lymphocytes may express integri

81 hypoxemic respiratory failure with bilateral pulmonary infiltrates that are not attributed to left at

82 considered in the differential diagnosis of pulmonary infiltrates that occur acutely after bone marr

83 who developed fever, hypoxia, and bilateral pulmonary infiltrates two and a half years after orthoto

84 Pugin score >6 in patients with pulmonary infiltrates warrants antimicrobial therapy.

85 except BAL PCRs to identify the etiology of pulmonary infiltrate was defined as standard-of-care.

86 Overall mortality in patients with pulmonary infiltrates was 28% (11 of 40); pneumonia as e

87 who were undergoing bronchoscopy because of pulmonary infiltrates was analyzed.

88 Pulmonary infiltrates, which are a hallmark of COVID-19

89 etection in upper respiratory tract with new pulmonary infiltrates with/without LRTD symptoms), proba

90 , and proven (PIV detection in lung with new pulmonary infiltrates with/without LRTD symptoms).